References

1. Capocaccia R, Colonna M, Corazziari I, et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. Annals of Oncology 2002; 13: 831-9.

2. Micheli A, Mugno E, Krogh V, et al. Cancer prevalence in European registry areas. Annals of Oncology 2002; 13: 840-65.

3. De Angelis R, Grande E, Inghelmann R et al. Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 2007; 93: 392-7.

4. Statistics Canada. Cancer Incidence in Canada (Catalogue 82-231-X 2008001) Ottawa: Minister of Industry, 2008.

5. Statistics Canada. Cancer Survival Statistics (Catalogue 82-226-X 2008001. Ottawa: Minister of Industry, 2008.

6. Ellison LF, Gibbons L. Leading cancers—changes in five-year relative survival.  Health Reports (Statistics Canada, Catalogue 82-203) 2004; 15(2): 21-33.

7. Ellison LF, Gibbons L. Survival from cancer—up-to-date predictions using period analysis. Health Reports (Statistics Canada, Catalogue 82-003) 2006; 17(2): 19-30.

8. Ellison LF, Pogany L, Mery LS.  Childhood and adolescent cancer survival:  A period analysis of data from the Canadian Cancer Registry. European Journal of Cancer 2007; 43: 1967-75.

9. National Cancer Institute of Canada. Canadian Cancer Statistics 2003. Toronto: National Cancer Institute of Canada, 2003.

10. Canadian Cancer Society and National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto:  Canadian Cancer Society and National Cancer Institute of Canada, 2008.

11. Statistics Canada. Canadian Cancer Registry. Ottawa: Health Statistics Division, Statistics Canada. Accessed January, 2009.

12. Statistics Canada. Demographic Estimates Compendium 2007 (Catalogue 91-213-SCB) Ottawa: Minister of Industry, 2008.

13. Parkin DM, Chen VW, Ferlay J, et al. Comparability and Quality Control in Cancer Registration. (IARC Technical Publications No. 19) Lyon: International Agency for Research on Cancer, 1994.

14. Fritz A, Percy C, Jack A, et al., eds. International Classification of Diseases for Oncology, Third Edition. Geneva: World Health Organization, 2000.

15. Ries LAG, Melbert D, Krapcho M et al., eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, Maryland: National Cancer Institute, 2008. 

16. Feldman AR, Kessler L, Myers MH et al. The prevalence of cancer. Estimates based upon the Connecticut tumor registry. The New England Journal of Medicine 1986; 315: 1394-7.

17. Gail MH, Kessler L, Midthune D, et al. Two approaches for estimating disease prevalence from population-based registries of incidence and mortality. Biometrics 1999; 55: 1137-44.

18. Statistical Research and Applications Branch, National Cancer Institute. Joinpoint Regression Program, Version 3.3 – April 2008. Place of publication: Statistical Research and Applications Branch, National Cancer Institute, 2008.

19. Colonna M, Danzon A, Delafosse P et al. Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012. European Journal of Cancer 2008; 44: 115-22.

20. Howe HL, Lake A, Firth R, et al., eds. Cancer in North America, 2001-2005. Volume Two: Registry-specific Cancer Incidence in the United States and Canada. Springfield, Illinois: North American Association of Central Cancer Registries, Inc., 2008.

21. Brisson J, Major D, Pelletier E. Évaluation de l’exhaustivité du fichier des tumeurs du Québec. Quebec: Institut national de la santé publique du Québec, 2003.

22. Capocaccia R, De Angelis R. Estimating the completeness of prevalence based on cancer registries data. Statistics in Medicine 1997; 16: 425-40.

23. Coldman AJ, McBride ML, Braun T. Calculating the prevalence of cancer. Statistics in Medicine 1992; 11: 1579-89.

24. Curado MP, Edwards B, Shin HR, et al., eds. Cancer Incidence in Five Continents, Vol. IX. (IARC Scientific Publications No. 160) Lyon: International Agency for Research on Cancer, 2007.

25. Segi, M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Department of Public Health, Tohoku University of Medicine, 1960.